Summary of Product Characteristics
last updated on the eMC:
13/05/2011
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 13/05/2011 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.8 - Undesirable Effects
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 01-Apr-2011 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Reason for change: Update to SmPC section 4.8 (Undesirable effects) to replace the current text with the following text ‘Immune system disorder: hypersensitivity reactions, including anaphylaxis.’
|
|
Updated on 12/10/2010 and displayed until 13/05/2011
|
Reasons for adding or updating:
|
|
|
| Date of revision of text on the SPC: |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| None provided |
|
